Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Elanco Animal Health Inc

Get SEC filing alerts via email and in your feed for Elanco Animal Health Inc

ELAN

Elanco Animal Health Inc

About Elanco Animal Health Inc

Elanco Animal Health Inc. is a global leader in animal health, providing products and services for pets and farm animals. Its portfolio includes parasiticides, vaccines, therapeutics, antibiotics, and feed additives, serving markets worldwide. The company focuses on innovation, portfolio optimization, and sustainability to improve animal well-being, food safety, and environmental impact, supporting farmers, pet owners, and veterinarians across diverse species and regions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Elanco Animal Health Inc

1
1
Elanco Animal Health Inc Elanco Reports $1.371 Billion Revenue in Q1 2026, 15% Increase Year-Over-Year

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Elanco Animal Health Inc Elanco Reports $4.715 Billion Revenue with 6% Increase, Faces $232 Million Net Loss

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Elanco Animal Health Inc Elanco Reports $1.137 Billion Revenue in Q3 2025, Faces $34 Million Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Elanco Animal Health Inc Elanco Reports 5% Revenue Growth to $1.241 Billion in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Elanco Animal Health Inc Elanco Reports $67 Million Net Income in Q1 2025, Revenue Declines 1% to $1.193 Billion

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Elanco Animal Health Inc Elanco Animal Health Reports Revenue Increase to $4.439 Billion for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Elanco Animal Health Inc Elanco Animal Health Reports Improved Profitability, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments